A research study for women with endometriosis at the NIH

The National Institutes of Health Clinical Center is seeking women with endometriosis and pelvic pain to participate in a research study.

Previous studies have shown that botulinum toxin injection may reduce pain and spasm of the pelvic floor.

However, more research is needed to test of botolinum toxin is an effective treatment or pelvic floor spasm in women with pelvic pain.

You may be eligible to participate in this study if you:

  • Are a woman aged 18 – 50 years old.
  • Have been surgically diagnosed with endometriosis and have persistent pelvic pain.

You may not be eligible for this study if you:

  • Have had a hysterectomy.
  • Have a history of urinary incontinence, fecal incontinence, or pelvic prolapse.
  • Have any other conditions which may be causing pelvic pain such as gastrointestinal, psychological disorders, fibromyalgia, or chronic fatigue syndrome.
  • Have an allergy to albumin or botulin toxin.

The NIH study involves:

  • Two or more outpatient visits to the NIH Clinical Center over a period of one month.
  • Two follow-up visits following the study injection.
  • Receiving either botulinum toxin or placebo (salt water) injection.
  • After the study injection, you may receive one botulinum injection during the one year follow-up period.
  • Study-related tests and medications are provided at no cost.

The study takes place at:

The NIH Clinical Center, America’s research hospital, in Bethesda (Maryland), USA.
It is on the Metro red line (Medical Center stop).

For more information:

Call 1-800-411-1222
Go online to clinicaltrials.gov and search by study #12-CH-0083

Stay up to date

Register for endometriosis news:


Recommend, read later, or share this article


Twitter Follow us on Twitter

Get involved

Help us improve treatments for endometriosis and prevent this disease in the next generation of women. Support the work of the World Endometriosis Research Foundation.

Donate to research Shop for WERF Volunteer